Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ENVISTA HOLDINGS CORPORATION

(NVST)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/20/2021 10/21/2021 10/22/2021 10/25/2021 10/26/2021 Date
38.92(c) 38.75(c) 39.07(c) 38.46(c) 38.73 Last
1 205 109 749 268 560 035 1 244 503 376 537 Volume
+0.36% -0.44% +0.83% -1.56% +0.70% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 2 827 M - -
Net income 2021 277 M - -
Net Debt 2021 690 M - -
P/E ratio 2021 24,0x
Yield 2021 -
Sales 2022 2 900 M - -
Net income 2022 299 M - -
Net Debt 2022 363 M - -
P/E ratio 2022 23,2x
Yield 2022 -
Capitalization 6 202 M 6 202 M -
EV / Sales 2021 2,44x
EV / Sales 2022 2,26x
Nbr of Employees 12 400
Free-Float 99,6%
More Financials
Company
Envista Holdings Corporation is a dental products company. The Company provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The Company operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental... 
More about the company
Ratings of Envista Holdings Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about ENVISTA HOLDINGS CORPORATION
06:27aBofA Securities Upgrades Envista Holdings to Buy From Neutral; Price Target is $48
MT
10/11ENVISTA : Schedules Third Quarter 2021 Earnings Call
PR
09/07ENVISTA : Agrees to Sell KaVo Treatment Unit And Instrument Business For up to $455 Millio..
MT
09/07ENVISTA : ANNOUNCES INTENDED SALE OF KAVO TREAMENT UNIT & INSTRUMENT BUSINESS TO PLANMECA ..
PU
09/07ENVISTA HOLDINGS CORP : Entry into a Material Definitive Agreement, Regulation FD Disclosu..
AQ
09/07ENVISTA : Announces Intended Sale Of KaVo Treatment Unit & Instrument Business To Planmeca
PR
09/07Planmeca Verwaltungs GmbH entered into a binding agreement to acquire KaVo Dental Treat..
CI
09/01ENVISTA : Announces Participation In Baird Global Healthcare Conference
PR
08/27ENVISTA HOLDINGS CORP : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, F..
AQ
08/27ENVISTA : SECOND AMENDED AND RESTATED BYLAWS OF (Form 8-K)
PU
08/04ENVISTA : JPMorgan Adjusts Price Target on Envista Holdings to $55 From $50, Maintains Ove..
MT
08/04ENVISTA : Piper Sandler Adjusts Price Target on Envista Holdings to $47 From $45, Maintain..
MT
08/03ENVISTA : Q2 Earnings Snapshot
AQ
08/03ENVISTA : REPORTS SECOND QUARTER 2021 RESULTS (Form 8-K)
PU
08/03ENVISTA : Management's Discussion and Analysis of Financial Condition and Results of Opera..
AQ
More news
News in other languages on ENVISTA HOLDINGS CORPORATION
09/13Deux valeurs dans la santé qui mériteraient d'être plus connues
More news
Analyst Recommendations on ENVISTA HOLDINGS CORPORATION
More recommendations
Chart ENVISTA HOLDINGS CORPORATION
Duration : Period :
Envista Holdings Corporation Technical Analysis Chart | NVST | US29415F1049 | MarketScreener
Technical analysis trends ENVISTA HOLDINGS CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 11
Last Close Price 38,46 $
Average target price 50,30 $
Spread / Average Target 30,8%
EPS Revisions
Managers and Directors
Amir A. Aghdaei President, Chief Executive Officer & Director
Howard H. Yu Chief Financial Officer & Senior Vice President
R. Scott Huennekens Independent Chairman
Wendy Carruthers Independent Director
Christine A. Tsingos Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ENVISTA HOLDINGS CORPORATION14.02%6 202
ABBOTT LABORATORIES15.61%224 403
MEDTRONIC PLC5.48%166 288
BECTON, DICKINSON AND COMPANY-1.52%70 767
HOYA CORPORATION20.25%55 682
DEXCOM, INC.53.72%54 986